Airdate: Thursday, December 14, 2023 Season: 10 Episode: 28
Guest: Jack Vanden Heuvel
Dr. Jack Vanden Heuvel from Penn State University and INDIGO Biosciences answers questions from a recent webinar where he discusses methodologies for predicting drug-drug interactions using in vitro assays and gene expression studies.
Associated Webinar: How to Better Predict Potential Drug Interactions Early in the Discovery Process
Similar Podcasts
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments
Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.
#ExpertAnswers: Travis Hardcastle and Seth Hanson on Using CRISPR and iPSCs for Neuroscience Research
Travis Hardcastle and Seth Hanson answer questions from a webinar where they discuss innovative applications of CRISPR and iPSCs in disease modeling and drug discovery.
#ExpertAnswers: Lorcan Sherry and Aditya Pratapa on Analyzing Multiplex Immunofluorescence Images
Dr. Lorcan Sherry and Dr. Aditya Pratapa answer questions from a recent webinar where they present a novel workflow for analyzing multiplex immunofluorescence images.
Related Content
Clambake: An Algorithm to Decode Energy Expenditure Data from Metabolic Cages
In this webinar, Dr. Jonathan Brestoff discusses his research on metabolism and a new method to quantify metabolic data known as Clambake.
Innovative Approaches to Assessing Thyroid Disruption: The 3D Human Thyroid Microtissue Model
Dr. Chad Deisenroth, PhD, from the US EPA, introduces an advanced human in vitro 3D thyroid microtissue model designed to evaluate thyroid hormone disruption, addressing current challenges with existing models.
Molecular Signals Mediating Increases in Muscle Size and Function
In this webinar, Dr. Bert Blaauw elucidates skeletal muscle regulatory pathways and offers approaches to tackle muscle deficits for therapy.